IRIS

Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients

Guasti, Luigina;Mugellini, Amedeo;Maffioli, Pamela;Derosa, Giuseppe
2017-01-01
2017
The Cardiovascular & Respiratory Systems category covers resources concerned with all aspects of cardiovascular and thoracic surgery and respiratory diseases. Topics include circulation, cardiovascular technology and measurement, cardiovascular pharmacology and therapy, hypertension, heart and lung transplantation, arteries, arteriosclerosis, thrombosis, angiology, perfusion, stroke, as well as all types of respiratory and lung diseases.
DRUG DESIGN, DEVELOPMENT AND THERAPY
sì
2-s2.0-85027262310
Esperti anonimi
Inglese
Internazionale
ELETTRONICO
11
2293
2300
8
28831241
ACE inhibitors; Ambulatory blood pressure; AT1R antagonist; Canrenone; RAAS; Pharmacology; 3003; Drug Discovery3003 Pharmaceutical Science
https://www.dovepress.com/getfile.php?fileID=37808
no
12
info:eu-repo/semantics/article
262
Guasti, Luigina; Gaudio, Giovanni; Lupi, Alessandro; Dâ avino, Marinella; Sala, Carla; Mugellini, Amedeo; Vulpis, Vito; Felis, Salvatore; Sarzani, Ri...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1203248
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact